Safety and efficacy of femoral vascular closure devices in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction

详细信息    查看全文

• 作者：Ó ; scar Prada-Delgado MD^a ; Rodrigo Est&#xe9 ; vez-Loureiro MD ; ^a ; ^{rodrigo.estevez.loureiro@sergas.es"" rel=""nofollow} ; Ramó ; n Calviñ ; o-Santos MD^a ; Eduardo Barge-Caballero PhD^a ; Jorge Salgado-Fern&#xe1 ; ndez MD^a ; Pablo Piñ ; ó ; n-Esteban MD^a ; Jose Manuel V&#xe1 ; zquez-Rodr&#xed ; guez PhD^a ; Guillermo Aldama-Ló ; pez MD^a ; Xacobe Flores-R&#xed ; os PhD^a ; Mar&#xed ; a Rita Soler-Mart&#xed ; n PhD^a ; Nicol&#xe1 ; s V&#xe1 ; zquez-Gonz&#xe1 ; lez MD^a ; Alfonso Castro-Beiras PhD^a
• 刊名：American Heart Journal
• 出版年：2011
• 出版时间：June 2011
• 年：2011
• 卷：161
• 期：6
• 页码：1207-1213
• 全文大小：181 K

文摘

Background

The use of vascular closure devices (VCDs) for the reduction of access site complications following percutaneous coronary intervention (PCI) remains controversial. Patients undergoing primary PCI for acute ST-segment elevation myocardial infarction (STEMI) are at high risk of femoral artery complications. A lack of information exists regarding the use of VCDs in this group of patients because they have been routinely excluded from randomized trials. This study sought to evaluate the safety and efficacy of the routine use of VCDs after primary PCI.

Methods

A total of 558 consecutive patients undergoing primary PCI for STEMI via femoral route were studied for in-hospital outcomes through a prospective registry from January 2003 to December 2008. The primary end point was the presence of major vascular complication (MVC) defined as a composite of fatal access site bleeding, access site complication requiring interventional or surgical correction, or access site bleeding with ≥3 g/dL drop in hemoglobin or requiring blood transfusion.

Results

Of the total patients, 464 (83.2 % ) received a VCD; and manual compression was used in 94 patients (16.8 % ). Major vascular complication occurred in 5.2 % of patients. The risk of MVC was significantly lower with VCDs compared with manual compression (4.3 % vs 9.6 % , P = .036). Multivariable logistic regression analysis determined that VCD use remained an independent predictor of lower rate of MVC (odds ratio 0.38, 95 % CI 0.17-0.91).

Conclusions

The use of VCDs in patients undergoing primary PCI for STEMI is safe and is associated with lower rates of MVC compared with manual compression.